EWTX - Edgewise Therapeutics GAAP EPS of -$0.36 May, 11 2023 11:44 AM Edgewise Therapeutics Inc. 2023-05-11 11:44:17 ET Edgewise Therapeutics press release ( NASDAQ: EWTX ): Q1 GAAP EPS of -$0.36. Cash, cash equivalents and marketable securities of $328 million as of March 31, 2023 For further details see: Edgewise Therapeutics GAAP EPS of -$0.36